Beijing Aosaikang Pharmaceutical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jingfei Ma
Chief executive officer
CN¥900.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 5.9yrs |
Recent management updates
Recent updates
Optimistic Investors Push Beijing Aosaikang Pharmaceutical Co., Ltd. (SZSE:002755) Shares Up 35% But Growth Is Lacking
Oct 18
Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt Sensibly?
Oct 11Beijing Aosaikang Pharmaceutical's (SZSE:002755) Earnings Are Weaker Than They Seem
Sep 05Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues
May 21Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?
Apr 29There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump
Mar 13CEO
Jingfei Ma (36 yo)
3.3yrs
Tenure
CN¥900,000
Compensation
Mr. Jingfei Ma is GM & Director of Beijing Aosaikang Pharmaceutical Co., Ltd. from February 18, 2022 and has been its Company Secretary since September 30, 2021.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM, Board Secretary & Director | 2.9yrs | CN¥900.00k | no data | |
| Deputy GM & Director | 5.9yrs | CN¥2.00m | no data | |
| Independent Director | 5.9yrs | CN¥100.00k | no data | |
| Chairman | no data | CN¥1.89m | no data | |
| Independent Director | 5.9yrs | CN¥100.00k | no data | |
| Non-Independent Director | 5.9yrs | CN¥1.00m | no data | |
| Independent Director | 5.9yrs | CN¥100.00k | no data | |
| Chairman of the Supervisory Board | 5.9yrs | no data | no data | |
| Non-Independent Director | 2.9yrs | CN¥670.00k | 0.00078% CN¥ 93.8k | |
| Non-Independent Director | 3.7yrs | no data | no data | |
| Employee Supervisor | 2.9yrs | no data | 0.00048% CN¥ 57.7k | |
| Employee Supervisor | 2.9yrs | no data | no data |
5.9yrs
Average Tenure
56yo
Average Age
Experienced Board: 002755's board of directors are considered experienced (5.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 12:42 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Aosaikang Pharmaceutical Co., Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shitong Han | Citic Securities Co., Ltd. |
| Yinhao Tang | Citic Securities Co., Ltd. |
| Wei Zheng | Tianfeng Securities Brokerage Co., Ltd |